Back to search

University of Peloponesse

Εταιρική υπευθυνότητα στον κλάδο παραγωγής - εμπορίας φαρμακευτικών, βιοτεχνολογικών προϊόντων και ιατρικού εξοπλισμού στην Ελλάδα

Abstract

dc:description

Introduction: Corporate Social Responsibility (CSR) is an emerging management tool and research field in all advanced societies. In Greece, a large percentage of businesses are convinced of the need to implement CSR practices, but the long-term socio-economic crisis and the COVID-19 pandemic, combined with the weakened CSR culture, have prevented its rapid growth. Objective: The aim of this thesis is to investigate corporate responsibility in the health technology industry in Greece. In particular, the implementation, scope and extent of CSR activities, the factors that influence its promotion and the potential for its development in Greece are investigated. Methodology: A cross-sectional study through stratified sampling was conducted in companies of the Hellenic Association of Pharmaceutical Companies (SFEE), the Panhellenic Association of Pharmaceutical Industry (PEF) and the Association of Medical and Biotechnology Companies (SEIV), from April 2021 to June 2021. The data collection was carried out using an anonymous, self-completed questionnaire that included the following categories of questions: a) demographic characteristics of a sample, b) fields of CSR activity, c) CSR and pandemic (COVID-19) and d) CSR and institutionalization. Mean values and standard deviations were used to describe the quantitative variables. Absolute (n) and relative (%) frequencies were used to describe the qualitative variables. Descriptive and multivariate statistical analyses were performed using SPSS 25.0. The inferential statistics were performed by applying Pearson's chi-squared test (χ2 test). The variables were irregularly distributed, and non-parametric controls were selected. The statistical significance of the difference between two independent groups was assessed using the Mann Whitney test and between three groups using the Kruskal Wallis test. Significance levels were bilateral and statistical significance was set at 0.05. Results: 74 companies constituted the final sample of this doctoral dissertation, giving a response rate of 77.7%. The majority of the participating companies are multinational companies in Greece (62.2%) and are active in the production/ marketing of medicines (40.5%), with an annual turnover ≥ € 40,000,000 (45.9%). 89.2% stated that they implement CSR actions and 42.2% of them apply for more than 10 years, paying annually up to € 100,000 for relevant actions. In addition, 70.3% stated that they do not have an independent CSR department in the company, and the responsible coordination department is the Board of Directors (43.2%) which does not have relevant expertise (62.2%), but the majority of the sample (83.8%) believes that the existence of an independent CSR department would contribute significantly to the actions. Health - Public Health (37.7%) is the main sector of CSR actions, which is mainly supported by the sponsorship of medical devices / equipment (45.9%). 75.7% said that contribution to society as a whole is the most important encouraging factor for CSR actions, while bureaucracy (45.9%) is the main deterrent. 67.6% respond to the requests/ complaints of consumers, suppliers and partners and implement strategic social investment actions, mainly for patient empowerment (56.8%). The majority of the sample stated that it adequately trains its employees about CSR (35.1%) and their participation in voluntary actions (32.4%) and for the protection of the environment, it implements environmental management systems (35.1%). Regarding CSR actions during the pandemic (COVID-19), 75.7% implemented relevant actions and 62.2% paid up to 15% of the total budget to address the pandemic. In addition, while 37.8% said their sales during the pandemic remained stable, 48.6% reported that their planning for CSR actions increased. Moreover, during the pandemic, the sponsorship of medical devices / equipment (37.8%), the information campaign on issues related to the protection of public health (37.8%) and the improvement of health unit infrastructure, equipment maintenance (37.8%) were very important CSR actions. Regarding the institutionalization of CSR, 97.3% stated that the State should reward socially responsible companies and provide them with relevant incentives (91.9%), while transparent work should be the main criterion for the company's inclusion in an institutionalised reward system (78.4%). The comparison and processing of the corporate characteristics of the sample significantly modify the results. Specifically, the category of business (national – multinational), the sector of activity (production / trade of medicine - production / marketing of medical equipment, & biotechnological products and the combination of the two previous categories), the turnover of the company and the number of employees significantly change the actions and ways of implementing CSR. Conclusions: Health technology companies in Greece participate in CSR initiatives. The findings and conclusions of this PhD thesis should be taken into account both by the State and companies in order to implement coordinated CSR programs that will bring positive results at the social, environmental and business level.

Degree

thesis:*
Grantor dc:publisher
University of Peloponesse
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Liopa, Margarita
  • Λιόπα, Μαργαρίτα

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/54490

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Liopa, Margarita; Λιόπα, Μαργαρίτα. Εταιρική υπευθυνότητα στον κλάδο παραγωγής - εμπορίας φαρμακευτικών, βιοτεχνολογικών προϊόντων και ιατρικού εξοπλισμού στην Ελλάδα. University of Peloponesse, 2023. http://hdl.handle.net/10442/hedi/54490